BU-NOT-SET

CONTACT US
A CDMO’s insight into the pharma M&A landscape
  • Industry trends
Eyes
Insight
Recipharm’s continuous global support throughout the COVID-19 pandemic
  • Industry trends
Eyes
Insight
Is outsourcing the most viable pathway for innovators?
  • Manufacturing
Meeting
Insight
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
  • Drug product
Two lab workers
Case study
Recipharm Wins two 2020 CMO Leadership Awards
  • Industry trends
Eyes
Insight
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
  • Corporate
Eyes
Insight
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Insight
  • Drug product
  • Manufacturing
Using blow-fill-seal technology for biologic and vaccine delivery
Webinar
Webinar: Understanding the benefits of blow-fill-seal unidose for ophthalmics, as an alternative to glass vials
Insight
  • Industry trends
  • Manufacturing
A leading global CDMO, renowned for its reliable & on-time offerings
Insight
  • Biologics
Navigating challenges in progressing breakthrough RNA therapeutics
Report
  • Sustainability
Sustainability report 2023
Insight
  • Industry trends
  • Manufacturing
Navigating pre-filled syringe filling complexities
Insight
  • Industry trends
  • Manufacturing
New product introduction: key to getting innovations from pilot to product
Case study
  • Drug product
Tackling antimicrobial resistance
Insight
  • Biologics
A new centre for continuous mRNA manufacturing